135 related articles for article (PubMed ID: 12530033)
1. Breast cancer in Nigeria and Finland: epidemiological, clinical and histological comparison.
Ikpatt OF; Kuopio T; Ndoma-Egba R; Collan Y
Anticancer Res; 2002; 22(5):3005-12. PubMed ID: 12530033
[TBL] [Abstract][Full Text] [Related]
2. The severity, outcome and challenges of breast cancer in Nigeria.
Adesunkanmi AR; Lawal OO; Adelusola KA; Durosimi MA
Breast; 2006 Jun; 15(3):399-409. PubMed ID: 16085418
[TBL] [Abstract][Full Text] [Related]
3. Histopathological types of breast cancer in Nigerian women: a 12-year review (1993-2004).
Ekanem VJ; Aligbe JU
Afr J Reprod Health; 2006 Apr; 10(1):71-5. PubMed ID: 16999196
[TBL] [Abstract][Full Text] [Related]
4. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers.
Bharat A; Gao F; Margenthaler JA
Am J Surg; 2009 Oct; 198(4):516-9. PubMed ID: 19800459
[TBL] [Abstract][Full Text] [Related]
5. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of necrosis in Nigerian breast cancer.
Ikpatt O; Ndoma-Egba R; Collan Y
Adv Clin Path; 2002 Jan; 6(1):31-7. PubMed ID: 17582946
[TBL] [Abstract][Full Text] [Related]
7. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
[TBL] [Abstract][Full Text] [Related]
8. Breast malignancies in a tertiary health setting in north-eastern Nigeria: a histopathological review.
Mayun AA; Obiano SK; Shehu SK; Abdulazeez JO
Afr J Med Med Sci; 2009 Dec; 38(4):337-41. PubMed ID: 20499627
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis in breast cancer: Nigerian vs. Finnish material.
Ikpatt F; Kuopio T; Erekul A; Collan Y
Anal Quant Cytol Histol; 2002 Apr; 24(2):73-80. PubMed ID: 12026053
[TBL] [Abstract][Full Text] [Related]
10. Tubular differentiation in African breast cancer.
Ikpatt OF; Kuopio T; Collan Y; Ndoma-Egba R
Adv Clin Path; 2003 Jan; 7(1):27-32. PubMed ID: 19774734
[TBL] [Abstract][Full Text] [Related]
11. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.
Santiago RJ; Harris EE; Qin L; Hwang WT; Solin LJ
Cancer; 2005 Jun; 103(12):2447-54. PubMed ID: 15887223
[TBL] [Abstract][Full Text] [Related]
12. Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma.
Thurman SA; Schnitt SJ; Connolly JL; Gelman R; Silver B; Harris JR; Recht A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):152-9. PubMed ID: 15093911
[TBL] [Abstract][Full Text] [Related]
13. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
[TBL] [Abstract][Full Text] [Related]
14. Breast carcinoma in women 35 years and younger: a pathological study.
Fernandopulle SM; Cher-Siangang P; Tan PH
Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
[TBL] [Abstract][Full Text] [Related]
15. Is pleomorphic lobular carcinoma really a distinct clinical entity?
Buchanan CL; Flynn LW; Murray MP; Darvishian F; Cranor ML; Fey JV; King TA; Tan LK; Sclafani LM
J Surg Oncol; 2008 Oct; 98(5):314-7. PubMed ID: 18668643
[TBL] [Abstract][Full Text] [Related]
16. Cancer of the male breast: analysis of forty-three cases in Ibadan, Nigeria.
Aghadiuno PU
Afr J Med Med Sci; 1987 Mar; 16(1):15-26. PubMed ID: 3037871
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer during pregnancy and lactation in Zaria, Nigeria.
Hassan I; Muhammed I; Attah MM; Mabogunje O
East Afr Med J; 1995 May; 72(5):280-2. PubMed ID: 7555881
[TBL] [Abstract][Full Text] [Related]
18. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
Ji J; Hemminki K
Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
[TBL] [Abstract][Full Text] [Related]
19. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
Skowronek J; Piotrowski T
Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
[TBL] [Abstract][Full Text] [Related]
20. Clinical-pathologic features and long-term outcomes of tubular carcinoma of the breast compared with invasive ductal carcinoma treated with breast conservation therapy.
Liu GF; Yang Q; Haffty BG; Moran MS
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1304-8. PubMed ID: 19386432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
